[
  {
    "ts": null,
    "headline": "He START Center for Cancer Research Doses First U.S. Patient in Moderna's Phase 1 Clinical Trial of mRNA-4106, A Pan-Tumor Antigen Therapy Candidate, in Solid Tumors",
    "summary": "The START Center for Cancer Research announced the dosing of the first U.S. participant in Moderna 's Phase 1 study evaluating mRNA-4106, a novel Pan-Tumor Antigen Therapy candidate, in patients with...",
    "url": "https://finnhub.io/api/news?id=09c24422b960084ee933b927795f94dd1cf9fc85735f9daef7098e8569a44673",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747302639,
      "headline": "He START Center for Cancer Research Doses First U.S. Patient in Moderna's Phase 1 Clinical Trial of mRNA-4106, A Pan-Tumor Antigen Therapy Candidate, in Solid Tumors",
      "id": 134467510,
      "image": "",
      "related": "MRNA",
      "source": "Finnhub",
      "summary": "The START Center for Cancer Research announced the dosing of the first U.S. participant in Moderna 's Phase 1 study evaluating mRNA-4106, a novel Pan-Tumor Antigen Therapy candidate, in patients with...",
      "url": "https://finnhub.io/api/news?id=09c24422b960084ee933b927795f94dd1cf9fc85735f9daef7098e8569a44673"
    }
  }
]